Friday, July 10, 2026

Drug profile · INN

diphtheria + tetanus vaccine

diphtheria + tetanus vaccine (ADT BOOSTER) is an FDA-listed pharmaceutical active ingredient. Associated with Seqirus (Australia) Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — diphtheria + tetanus vaccine

Quick answer

diphtheria + tetanus vaccine (ADT BOOSTER) is an FDA-listed pharmaceutical active ingredient. Associated with Seqirus (Australia) Pty Ltd.

Key facts

INN diphtheria + tetanus vaccine
Brand ADT BOOSTER

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Booster Sessions Phase 3 · BRIGHT MINDS BIOSCIENCES · Skill Development of Staff
  2. BOOST cells Phase 2 · George Institute for · Osteogenesis Imperfecta (OI) type III and severe type IV. Se
  3. Boost to the tumour bed Unknown · United Therapeutics Europe · Early Breast Cancer

Frequently asked questions

What is diphtheria + tetanus vaccine?

diphtheria + tetanus vaccine (ADT BOOSTER) is an FDA-listed pharmaceutical active ingredient. Associated with Seqirus (Australia) Pty Ltd.

What is the brand name for diphtheria + tetanus vaccine?

ADT BOOSTER is a marketed brand name for diphtheria + tetanus vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.